87 related articles for article (PubMed ID: 26526)
1. The disposition of 3-deazauridine in mice.
Cysyk RL; Gormley PE; D'Anna ME; Adamson RH
Drug Metab Dispos; 1978; 6(2):125-32. PubMed ID: 26526
[No Abstract] [Full Text] [Related]
2. Pharmacokinetics and disposition of 3-deazauridine in humans.
Benvenuto JA; Hall SW; Farquhar D; Stewart DJ; Benjamin RS; Loo TL
Cancer Res; 1979 Feb; 39(2 Pt 1):349-52. PubMed ID: 761206
[TBL] [Abstract][Full Text] [Related]
3. Transport of uridine and 3-deazauridine in cultured human lymphoblastoid cells.
Dahlig-Harley E; Paterson AR; Robins MJ; Cass CE
Cancer Res; 1984 Jan; 44(1):161-5. PubMed ID: 6580947
[TBL] [Abstract][Full Text] [Related]
4. The effect of 3-deazauridine and dipyridamole on uridine utilization by mice.
Moyer JD; Malinowski N; Cysyk RL
Eur J Cancer Clin Oncol; 1986 Mar; 22(3):323-7. PubMed ID: 2423341
[TBL] [Abstract][Full Text] [Related]
5. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
Li ZR; Campbell J; Rustum YM
Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
[TBL] [Abstract][Full Text] [Related]
6. Synergistic action of 5-aza-2'-deoxycytidine and 3-deazauridine on L1210 leukemic cells and EMT6 tumor cells.
Momparler RL; Veselý J; Momparler LF; Rivard GE
Cancer Res; 1979 Oct; 39(10):3822-7. PubMed ID: 476619
[TBL] [Abstract][Full Text] [Related]
7. Regulation of pyrimidine biosynthesis in cultured L1210 cells by 3-deazauridine.
Karle JM; Cysyk RL
Biochem Pharmacol; 1984 Dec; 33(23):3739-42. PubMed ID: 6095859
[TBL] [Abstract][Full Text] [Related]
8. The mechanism of action of 3-deazauridine in tumor cells sensitive and resistant to arabinosylcytosine.
Brockman RW; Shaddix SC; Williams M; Nelson JA; Rose LM; Schabel FM
Ann N Y Acad Sci; 1975 Aug; 255():501-21. PubMed ID: 171997
[TBL] [Abstract][Full Text] [Related]
9. Dual effects of pyrazofurin and 3-deazauridine upon pyrimidine and purine biosynthesis in mouse L1210 leukemia.
Sant ME; Lyons SD; Kemp AJ; McClure LK; Szabados E; Christopherson RI
Cancer Res; 1989 May; 49(10):2645-50. PubMed ID: 2713848
[TBL] [Abstract][Full Text] [Related]
10. In vivo cellular kinetic and pharmacological studies of 1-beta-D-arabinofuranosylcytosine and 3-deazauridine chemotherapy for relapsing acute leukemia.
Barlogie B; Plunkett W; Raber M; Latreille J; Keating M; McCredie K
Cancer Res; 1981 Mar; 41(3):1227-35. PubMed ID: 7459863
[No Abstract] [Full Text] [Related]
11. Toxicity of combinations of arabinosylcytosine and 3-deazauridine toward neoplastic cells in culture.
Mills-Yamamoto C; Lauzon GJ; Paterson AR
Biochem Pharmacol; 1978 Jan; 27(2):181-6. PubMed ID: 623673
[No Abstract] [Full Text] [Related]
12. Phosphorylation of nucleosides catalyzed by a mammalian enzyme other than uridine-cytidine kinase.
Ahmed NK; Germain GS; Welch AD; Paterson AR; Paran JH; Yang S
Biochem Biophys Res Commun; 1980 Jul; 95(1):440-5. PubMed ID: 6158318
[No Abstract] [Full Text] [Related]
13. High-pressure liquid chromatographic analysis of 3-deazauridine-5'-triphosphate in human cancer cells.
Plunkett W; Benvenuto JA; Stewart DJ; Loo TL
Cancer Treat Rep; 1979 Mar; 63(3):415-20. PubMed ID: 284846
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate and 3-deazauridine 5'-triphosphate in human leukemia cells by high-performance liquid chromatography.
Plunkett W; Chubb S; Barlogie B
J Chromatogr; 1980 Dec; 221(2):425-30. PubMed ID: 6938519
[No Abstract] [Full Text] [Related]
15. Cytidine 5'-triphosphate synthetase as a target for inhibition by the antitumor agent 3-deazauridine.
McPartland RP; Wang MC; Bloch A; Weinfeld H
Cancer Res; 1974 Nov; 34(11):3107-11. PubMed ID: 4472653
[No Abstract] [Full Text] [Related]
16. Properties of uridine-cytidine kinase derived from L1210 leukemia cells.
Ahmed NK; Baker DR
Cancer Res; 1980 Oct; 40(10):3559-63. PubMed ID: 6254634
[TBL] [Abstract][Full Text] [Related]
17. Altered 5-azacytidine metabolism following 3-deazauridine treatment of L5178Y and human myeloblasts.
Grant S; Cadman E
Cancer Res; 1980 Nov; 40(11):4000-6. PubMed ID: 6162541
[TBL] [Abstract][Full Text] [Related]
18. Cytidine and deoxycytidylate deaminase inhibition by uridine analogs.
Drake JC; Hande KR; Fuller RW; Chabner BA
Biochem Pharmacol; 1980 Mar; 29(5):807-11. PubMed ID: 20227960
[TBL] [Abstract][Full Text] [Related]
19. Penetration of 3-deazauridine into human brain, intracerebral tumor, and cerebrospinal fluid.
Stewart DJ; Benvenuto JA; Leavens M; Hall SW; Benjamin RS; Plunkett W; McCredie KB; Burgess MA; Loo TL
Cancer Res; 1979 Oct; 39(10):4119-22. PubMed ID: 476649
[TBL] [Abstract][Full Text] [Related]
20. Drug sequence-dependent toxicity and small bowel mucosal injury in mice treated with low doses of 3-deazauridine and 1-beta-D-arabinofuranosylcytosine.
Paterson AR; Jakobs ES; Lauzon GJ; Weinstein WM
Cancer Res; 1979 Jun; 39(6 Pt 1):2216-9. PubMed ID: 445420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
